210 related articles for article (PubMed ID: 15623437)
1. Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation.
Heredia Mdel P; Delgado C; Pereira L; Perrier R; Richard S; Vassort G; Bénitah JP; Gómez AM
J Mol Cell Cardiol; 2005 Jan; 38(1):205-12. PubMed ID: 15623437
[TBL] [Abstract][Full Text] [Related]
2. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
Bell D; Millar BC; McDermott BJ
Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.
Jacques D; Sader S; El-Bizri N; Chouffani S; Hassan G; Shbaklo H
Can J Physiol Pharmacol; 2000 Feb; 78(2):162-72. PubMed ID: 10737679
[TBL] [Abstract][Full Text] [Related]
4. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
5. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells.
Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Duarte EP; Cavadas C
J Neurochem; 2007 Nov; 103(3):896-903. PubMed ID: 17868303
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors.
Alvaro AR; Rosmaninho-Salgado J; Ambrósio AF; Cavadas C
J Neurochem; 2009 Jun; 109(5):1508-15. PubMed ID: 19344373
[TBL] [Abstract][Full Text] [Related]
7. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
Allen AR; Kelso EJ; Bell D; Zhao Y; Dickson P; McDermott BJ
J Pharmacol Exp Ther; 2006 Dec; 319(3):1286-96. PubMed ID: 16973886
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.
Heredia MP; Fernández-Velasco M; Benito G; Delgado C
Br J Pharmacol; 2002 Apr; 135(7):1701-6. PubMed ID: 11934810
[TBL] [Abstract][Full Text] [Related]
9. Isoprenaline enhances local Ca2+ release in cardiac myocytes.
Shen JX
Acta Pharmacol Sin; 2006 Jul; 27(7):927-32. PubMed ID: 16787578
[TBL] [Abstract][Full Text] [Related]
10. Impact of testosterone on cardiac L-type calcium channels and Ca2+ sparks: acute actions antagonize chronic effects.
Er F; Michels G; Brandt MC; Khan I; Haase H; Eicks M; Lindner M; Hoppe UC
Cell Calcium; 2007 May; 41(5):467-77. PubMed ID: 17084891
[TBL] [Abstract][Full Text] [Related]
11. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
12. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes.
Völkers M; Loughrey CM; Macquaide N; Remppis A; DeGeorge BR; Wegner FV; Friedrich O; Fink RH; Koch WJ; Smith GL; Most P
Cell Calcium; 2007 Feb; 41(2):135-43. PubMed ID: 16919727
[TBL] [Abstract][Full Text] [Related]
13. Opioid receptor-mediated effects of interleukin-2 on the [Ca2+]i transient and contraction in isolated ventricular myocytes of the rat.
Cao CM; Xia Q; Chen YY; Zhang X; Shen YL
Pflugers Arch; 2002 Feb; 443(4):635-42. PubMed ID: 11907831
[TBL] [Abstract][Full Text] [Related]
14. [Effects of neuropeptide Y on ion channels in ventricular myocytes].
Zhao HC; Liu ZB; Feng QL; Cui XL; Zhang CM; Wu BW
Sheng Li Xue Bao; 2006 Jun; 58(3):225-31. PubMed ID: 16786106
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats.
Chen M; Li X; Dong Q; Li Y; Liang W
Regul Pept; 2005 Feb; 125(1-3):9-15. PubMed ID: 15582708
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
17. Metabolic inhibition alters subcellular calcium release patterns in rat ventricular myocytes: implications for defective excitation-contraction coupling during cardiac ischemia and failure.
Fukumoto GH; Lamp ST; Motter C; Bridge JH; Garfinkel A; Goldhaber JI
Circ Res; 2005 Mar; 96(5):551-7. PubMed ID: 15718501
[TBL] [Abstract][Full Text] [Related]
18. The signal transduction pathway causing the synergistic hypertrophic effects of neuropeptide Y and norepinephrine on primary cardiomyocyte.
Zeng C; Zhou Y; Liu G; Sun W
Neuropeptides; 2001; 35(5-6):211-8. PubMed ID: 12030804
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y is an essential in vivo developmental regulator of cardiac ICa,L.
Protas L; Barbuti A; Qu J; Rybin VO; Palmiter RD; Steinberg SF; Robinson RB
Circ Res; 2003 Nov; 93(10):972-9. PubMed ID: 14525809
[TBL] [Abstract][Full Text] [Related]
20. Receptor subtype involved in alpha 1-adrenergic receptor-mediated Ca2+ signaling in cardiomyocytes.
Luo DL; Gao J; Fan LL; Tang Y; Zhang YY; Han QD
Acta Pharmacol Sin; 2007 Jul; 28(7):968-74. PubMed ID: 17588332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
